Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Average Rating of “Moderate Buy” from Brokerages

Intuitive Surgical, Inc. (NASDAQ:ISRG) has been assigned an average rating of “Moderate Buy” from the twenty-seven research firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation, sixteen have given a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $609.8333.

ISRG has been the topic of a number of research analyst reports. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 24th. Piper Sandler raised their target price on Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 22nd. Jefferies Financial Group lifted their target price on Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. Finally, Raymond James Financial set a $603.00 price target on Intuitive Surgical and gave the company an “outperform” rating in a research note on Wednesday, October 22nd.

Insider Activity at Intuitive Surgical

In other news, insider Gary S. Guthart sold 28,800 shares of the company’s stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $547.56, for a total transaction of $15,769,728.00. Following the transaction, the insider owned 27,027 shares in the company, valued at approximately $14,798,904.12. This represents a 51.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO David J. Rosa sold 24,500 shares of the stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the transaction, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. This trade represents a 9.47% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 114,007 shares of company stock worth $63,533,844 over the last ninety days. 0.70% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Brighton Jones LLC lifted its holdings in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares in the last quarter. Colonial Trust Advisors raised its holdings in Intuitive Surgical by 5,000.0% during the first quarter. Colonial Trust Advisors now owns 102 shares of the medical equipment provider’s stock worth $51,000 after buying an additional 100 shares during the last quarter. Van Lanschot Kempen Investment Management N.V. grew its holdings in shares of Intuitive Surgical by 28.0% during the first quarter. Van Lanschot Kempen Investment Management N.V. now owns 30,635 shares of the medical equipment provider’s stock valued at $15,173,000 after buying an additional 6,702 shares during the last quarter. Vertex Planning Partners LLC increased its position in shares of Intuitive Surgical by 5.3% during the first quarter. Vertex Planning Partners LLC now owns 896 shares of the medical equipment provider’s stock worth $444,000 after acquiring an additional 45 shares in the last quarter. Finally, Erste Asset Management GmbH raised its holdings in shares of Intuitive Surgical by 6.5% in the 1st quarter. Erste Asset Management GmbH now owns 104,057 shares of the medical equipment provider’s stock worth $51,898,000 after acquiring an additional 6,381 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $556.86 on Thursday. The firm has a market cap of $199.62 billion, a price-to-earnings ratio of 73.66, a PEG ratio of 5.10 and a beta of 1.68. Intuitive Surgical has a 52-week low of $425.00 and a 52-week high of $616.00. The firm has a 50 day moving average price of $536.26 and a two-hundred day moving average price of $505.77.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same period in the prior year, the firm posted $1.84 EPS. The company’s quarterly revenue was up 22.9% on a year-over-year basis. As a group, equities research analysts predict that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.